The New York Times reports on a new treatment for eczema, which costs $37,000 per year.
However, a paper by the London School of Economics provides ample evidence that this high cost of R&D is as they say, a "myth". Or rather, creative accounting. Warning: PDF. I'm not going to try to summarize it but if drug costs are of concern to you, it's worth reading in full.